CELESTENE CHRONODOSE

This brand name is authorized in Estonia, France, Tunisia

Active ingredients

The drug CELESTENE CHRONODOSE contains a combination of these active pharmaceutical ingredients (APIs):

1 Betamethasone UNII TI05AO53L7 - BETAMETHASONE ACETATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

2 Betamethasone UNII 7BK02SCL3W - BETAMETHASONE SODIUM PHOSPHATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB01	Betamethasone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1322705
Country: FR	Base de données publique des médicaments	Identifier(s): 68791304
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6520027